Evidence map›Paper›PMID 41972034›Full record

ArticleQuantitative imaging in medicine and surgery2026

Comparison of artificial intelligence (AI) services for Breast Imaging-Reporting and Data System (BI-RADS) classification on mammograms.

Yuriy Vasilev, Anna Mayorova, Denis Rumyantsev, Serafim Semenov, Tatiana Bobrovskaya, Lev Pestrenin, Rustam Erizhokov, Anton Vladzymyrskyy, Olga Omelyanskaya, Kirill Arzamasov

Abstract read
In one paragraph

Article in Quantitative imaging in medicine and surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Yuriy VasilevResearch and Practical Clinical Center for Diagnostics and Telemedicine Technologies of the Moscow Health Care Department, Moscow, Russia.ORCID https://orcid.org/0000-0002-5283-5961
Anna MayorovaResearch and Practical Clinical Center for Diagnostics and Telemedicine Technologies of the Moscow Health Care Department, Moscow, Russia.ORCID https://orcid.org/0000-0002-8888-743X
Denis RumyantsevResearch and Practical Clinical Center for Diagnostics and Telemedicine Technologies of the Moscow Health Care Department, Moscow, Russia.ORCID https://orcid.org/0000-0001-7670-7385
Serafim SemenovResearch and Practical Clinical Center for Diagnostics and Telemedicine Technologies of the Moscow Health Care Department, Moscow, Russia.ORCID https://orcid.org/0000-0003-2585-0864
Tatiana BobrovskayaResearch and Practical Clinical Center for Diagnostics and Telemedicine Technologies of the Moscow Health Care Department, Moscow, Russia.ORCID https://orcid.org/0000-0002-2746-7554
Lev PestreninResearch and Practical Clinical Center for Diagnostics and Telemedicine Technologies of the Moscow Health Care Department, Moscow, Russia.ORCID https://orcid.org/0000-0002-1786-4329
Rustam ErizhokovResearch and Practical Clinical Center for Diagnostics and Telemedicine Technologies of the Moscow Health Care Department, Moscow, Russia.ORCID https://orcid.org/0009-0007-3636-2889
Anton VladzymyrskyyResearch and Practical Clinical Center for Diagnostics and Telemedicine Technologies of the Moscow Health Care Department, Moscow, Russia.ORCID https://orcid.org/0000-0002-2990-7736
Olga OmelyanskayaResearch and Practical Clinical Center for Diagnostics and Telemedicine Technologies of the Moscow Health Care Department, Moscow, Russia.ORCID https://orcid.org/0000-0002-0245-4431
Kirill ArzamasovResearch and Practical Clinical Center for Diagnostics and Telemedicine Technologies of the Moscow Health Care Department, Moscow, Russia.ORCID https://orcid.org/0000-0001-7786-0349

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Existing literature primarily focuses on artificial intelligence (AI) ability to detect malignant breast tumors, often neglecting or limiting analysis to Breast Imaging-Reporting and Data System (BI-RADS) categories 4 and 5. The diagnostic performance of AI for other BI-RADS categories remains understudied. The objective of this study is to compare the diagnostic accuracy of three mammographic AI services in predicting individual BI-RADS categories and definition of opportunity integration of AI into routine clinical practice. Methods: Anonymized mammograms were obtained from the Unified Radiological Information Service of Moscow. Inclusion criteria: screening mammogram, radiology report from an AI and a human radiologist, age patients 40-75 years. Exclusion criteria: mammograms without BI-RADS categories, BI-RADS categories 0 and 6. The AI performance was assessed by calculating their diagnostic performance using the radiologists' opinion as the ground truth together with the calibration tests. Results: The study sample consisted of 81,895 mammograms. Median accuracy was 76.9%, with a positive predictive value (PPV) of 11.8%. The highest negative predictive value (NPV) was observed for BI-RADS 2 (78.5-83.4%). The second highest NPVs were observed for BI-RADS 1, 3, 4, and 5 (over 84.7%). Binary classification yielded median accuracy and PPV values of 80.5% and 98.6% respectively, compared to the calibration testing (76.0% and 84.7%). Conclusions: Most AI service metrics were suboptimal for individual BI-RADS prediction, potentially due to reliance on variable radiologist conclusions and lack of histological calibration. Binary classification demonstrated higher performance metrics, and no significant differences in NPV were observed across AI applications, which means they can be recommended to confirm the absence of pathology. Successful integration of AI into routine clinical practice requires consideration of various diagnostic accuracy assessment methods, tailored to specific use cases.

Indexed as

artificial intelligence (AI)Breast cancer (BC)Breast Imaging-Reporting and Data System (BI-RADS)mammography

Identifiers

PMID41972034
PMCPMC13066832

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.